h1

h2

h3

h4

h5
h6

001     677087
005     20230211041515.0
024 7 _ |a G:(EU-Grant)723770
|d 723770
|2 CORDIS
024 7 _ |a G:(EU-Call)H2020-NMBP-ERA-NET-2016
|d H2020-NMBP-ERA-NET-2016
|2 CORDIS
024 7 _ |a corda__h2020::723770
|2 originalID
035 _ _ |a G:(EU-Grant)723770
150 _ _ |a ERA-NET ON NANOMEDICINE
|y 2016-11-01 - 2022-10-31
371 _ _ |a MINISTERO DELL'ISTRUZIONE, DELL'UNIVERSITA' E DELLA RICERCA
|b MIUR
|d Italy
|e http://www.istruzione.it
|v CORDIS
371 _ _ |a NORGES FORSKNINGSRAD
|b THE RESEARCH COUNCIL OF NORWAY
|d Norway
|e http://www.rcn.no
|v CORDIS
371 _ _ |a MINISTRY OF HEALTH
|b CSO-MOH
|d Israel
|e http://www.health.gov.il
|v CORDIS
371 _ _ |a Federal Ministry for Economic Affairs and Energy
|b BMWi
|d Germany
|e http://www.bmwi.de/EN/root.html
|v CORDIS
371 _ _ |a SIHTASUTUS EESTI TEADUSAGENTUUR
|b ETAg
|d Estonia
|e http://www.etag.ee
|v CORDIS
371 _ _ |a CENTRO PARA EL DESARROLLO TECNOLOGICO INDUSTRIAL.
|b CDTI
|d Spain
|e http://www.cdti.es
|v CORDIS
371 _ _ |a FONDS DE LA RECHERCHE SCIENTIFIQUE- FNRS
|d Belgium
|e http://www.frs-fnrs.be
|v CORDIS
371 _ _ |a TECHNOLOGICKA AGENTURA CESKE REPUBLIKY
|d Czech Republic
|e http://www.tacr.cz/index.php/en/
|v CORDIS
371 _ _ |a BULGARIAN NATIONAL SCIENCE FUND
|b BNSF
|d Bulgaria
|e http://www.fni.bg
|v CORDIS
371 _ _ |a TURKIYE BILIMSEL VE TEKNOLOJIK ARASTIRMA KURUMU
|b TUBITAK
|d Turkey
|e http://www.tubitak.gov.tr
|v CORDIS
371 _ _ |a Ministry of Science and Technology
|b MOST
|d Taiwan
|e https://www.most.gov.tw/en/
|v CORDIS
371 _ _ |a MINISTERO DELLA SALUTE
|d Italy
|e http://www.salute.gov.it
|v CORDIS
371 _ _ |a Ministerul Cercetării și Inovării
|b MCI
|d Romania
|e http://www.research.gov.ro/
|v CORDIS
371 _ _ |a Agence Nationale de la Recherche
|b ANR
|d France
|e http://www.agence-nationale-recherche.fr/en/project-based-funding-to-advance-french-research/
|v CORDIS
371 _ _ |a Unitatea Executiva pentru Finantarea Invatamantului Superior, a Cercetarii, Dezvoltarii si Inovarii
|b UEFISCDI
|d Romania
|e http://www.uefiscdi.gov.ro
|v CORDIS
371 _ _ |a STICHTING VOOR DE TECHNISCHE WETENSCHAPPEN
|b STW
|d Netherlands
|v CORDIS
371 _ _ |a AUTORITATEA NATIONALA PENTRU CERCETARE STIINTIFICA SI INOVARE
|b ANCSI
|d Romania
|e http://www.research.ro
|v CORDIS
371 _ _ |a Fonds de Recherche du Québec - Santé
|b FRQS
|d Canada
|e http://www.frqs.gouv.qc.ca/en/
|v CORDIS
371 _ _ |a GENIKI GRAMMATIA EREVNAS KAI TECHNOLOGIAS
|d Greece
|e http://www.gsrt.gr
|v CORDIS
371 _ _ |a NARODOWE CENTRUM BADAN I ROZWOJU
|b NCBR
|d Poland
|e http://www.ncbr.gov.pl
|v CORDIS
371 _ _ |a VALSTS IZGLITIBAS ATTISTIBAS AGENTURA
|b VIAA
|d Latvia
|e http://www.viaa.gov.lv
|v CORDIS
371 _ _ |a Lietuvos Mokslo Taryba
|b Lietuvos Mokslo Taryba
|d Lithuania
|e http://www.lmt.lt/en/news.html
|v CORDIS
371 _ _ |a VDI TECHNOLOGIEZENTRUM GMBH
|d Germany
|e http://www.vditz.de
|v CORDIS
371 _ _ |a Slovak Academy of Sciences
|b SAS
|d Slovakia
|e http://www.sav.sk/
|v CORDIS
371 _ _ |a SFI - Science Foundation Ireland
|b SFI
|d Ireland
|e http://www.sfi.ie/
|v CORDIS
371 _ _ |a Ministry of Economy, Industry and Competitiveness
|b MINECO
|d Spain
|e http://www.mineco.gob.es/
|v CORDIS
371 _ _ |a Instituto de Salud Carlos III
|b ISC
|d Spain
|e http://www.isciii.es/
|v CORDIS
371 _ _ |a Fundação para a Ciência e a Tecnologia
|b FCT
|d Portugal
|e https://www.fct.pt/
|v CORDIS
372 _ _ |a H2020-NMBP-ERA-NET-2016
|s 2016-11-01
|t 2022-10-31
450 _ _ |a EuroNanoMed III
|w d
|y 2016-11-01 - 2022-10-31
510 1 _ |0 I:(DE-588b)5098525-5
|a European Union
|2 CORDIS
680 _ _ |a Nanomedicine is the application of nanotechnology to medicine and healthcare. The field takes advantage of the physical, chemical and biological properties of materials at the nanometer scale to be used for a better understanding of the biological mechanisms of diseases at the molecular level, leading to new targets for earlier and more precise diagnostics and therapeutics. Nanomedicine, rated among the six most promising Key Enabling Technologies, is one of the most important emerging areas of health research expected to contribute to one of the strategic challenges that Europe has to face in the future: Provide effective and affordable health care and assure the wellbeing of an increasingly aged population. EuroNanoMed III (ENM III) builds on the foundations of ENM I & II, which launched 7 successful joint calls for proposals since 2009, funded 51 transnational research projects involving 269 partners from 25 countries/regions, and allocated € 45,5 million to research projects from ENM funding agencies. ENM III consortium, reinforced with 12 new partners from Europe, Canada and Taiwan, is committed to fostering the competiveness of European nanomedicine actors taking into account recent changes in the landscape and new stakeholders and challenges, as identified in the SRIA in nanomedicine. The first joint call for proposals will be co-funded by ENM III partners and the EC. After the co-funded call, three additional joint transnational calls will be organized and strategic activities will be accomplished in collaboration with key initiatives in the field. ENM III actions focus on translatability of project results to clinical and industry needs.
909 C O |o oai:juser.fz-juelich.de:823130
|p authority:GRANT
|p authority
909 C O |o oai:juser.fz-juelich.de:823130
970 _ _ |a oai:dnet:corda__h2020::71db77679ccab01b0c9460fd4494d113
980 _ _ |a G
980 _ _ |a CORDIS
980 _ _ |a AUTHORITY

LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21